Medicamentos E Saúde
Marevan 5mg 30 Comprimidos
Marevan- GTIN / EAN
- 7898244720234
- NCM
- 1704.10.00
- CEST
- Não informado
- Conteúdo
- Não informado
Dados de produto preservados no idioma original.
Marevan 5mg 30 Comprimidos é fabricado pela Marevan, na categoria Medicamentos E Saúde, com código de barras 7898244720234. Classificado no NCM 1704.10.00 (- Gomas de mascar (pastilhas elásticas), mesmo revestidas de açúcar).
Fonte: SI5 Global · código registrado em Brasil · atualizado em 02/10/2026
Preço base (referência): R$ 32,59 — coletado em paguemenos.com.br em 02/10/2026, pode não estar atualizado
Faixa de preço nos últimos 30 dias: R$ 31,27 a R$ 32,59 em 3 lojas
Classificação fiscal
- NCM
- 1704.10.00- Gomas de mascar (pastilhas elásticas), mesmo revestidas de açúcar
Descrição do produto
O que é Marevan 5mg 30 Comprimidos?
O Marevan 5mg 30 Comprimidos é um medicamento anticoagulante oral que contém varfarina sódica como princípio ativo. Sua principal função é inibir os fatores de coagulação que dependem da vitamina K, reduzindo a capacidade do sangue de formar coágulos. O objetivo do tratamento com Marevan é prevenir a formação de trombos e a ocorrência de tromboembolismo venoso, que é a obstrução de veias por coágulos. Este medicamento é essencial na prevenção de condições graves como o acidente vascular cerebral (AVC), infarto do miocárdio e embolismo sistêmico, especialmente em pacientes com condições cardíacas específicas, como próteses de válvulas ou fibrilação atrial, ajudando a manter o fluxo sanguíneo adequado e a evitar complicações.
Conteúdo da embalagem: 30 comprimidos de 5mg.
Fabricado por: Farmoquímica.
Indicação etária: Uso adulto.
Composição Marevan 5mg:
Princípio ativo: varfarina sódica 5mg.
Excipientes: lactose monoidratada, corante vermelho ponceau 4R, amido, amidoglicolato de sódio, estearato de magnésio e água.
Para que serve Marevan?
Marevan é um medicamento anticoagulante utilizado para reduzir a capacidade de coagulação do sangue. É indicado para:
- Prevenção primária e secundária do tromboembolismo venoso (formação de coágulos nas veias).
- Prevenção do embolismo sistêmico em pacientes com prótese de válvulas cardíacas ou fibrilação atrial.
- Prevenção do acidente vascular cerebral (AVC, derrame).
- Prevenção do infarto agudo do miocárdio e da sua recorrência.
- Prevenção do embolismo sistêmico em pacientes com doença valvular cardíaca.
Como devo tomar Marevan 5mg?
A administração de Marevan deve ser feita estritamente sob orientação médica, pois a dose é individual e ajustada com base em exames de sangue.
- A posologia deve ser individualizada pelo seu médico, com base nos resultados de exames de sangue (TP/RNI).
- A dose inicial recomendada é de 2,5mg a 5mg ao dia.
- A dose de manutenção geralmente varia de 2,5mg a 10mg ao dia.
- O comprimido deve ser engolido inteiro, com água, sem partir, abrir ou mastigar.
- Siga rigorosamente a orientação médica quanto aos horários, doses e duração do tratamento.
- Não interrompa o tratamento sem o conhecimento do seu médico.
Quando não devo tomar Marevan?
Você não deve utilizar Marevan nas seguintes situações:
- Em caso de gravidez, suspeita de gravidez ou se você pode ficar grávida durante o tratamento.
- Nas primeiras 24 horas antes ou após cirurgias ou parto.
- Em casos de aborto incompleto.
- Se tiver doenças hepáticas ou renais graves.
- Se apresentar hemorragias ativas.
- Se tiver hipertensão arterial grave não controlada.
- Em casos de endocardite bacteriana, aneurisma cerebral ou aórtico, e hemofilia.
- Se tiver doença ulcerativa ativa do trato gastrointestinal.
- Se tiver hipersensibilidade (alergia) à varfarina sódica ou a qualquer outro componente da fórmula.
Ficha técnica
- Medicamento
- True
- MarcaPropria
- Não
- NumeroRegistroMS
- 1.0390.0147.002-8
- DescricaoBula
- %0A%09%09%09%09%09%09%3Ch2%3ELaborat%26%23xF3%3Brio%3C%2Fh2%3E%0A%3Cp%3EFARMOQU%26%23xCD%3BMICA%3C%2Fp%3E%0A%3Ch2%3E%20Apresenta%26%23xE7%3B%26%23xE3%3Bo%20MAREVAN%20%3C%2Fh2%3E%0A%3Cp%3EComprimidos%20com%202%2C5%20mg%20%26%23x96%3B%20Embalagem%20contendo%2030%20ou%2060%20comprimidos.%3Cbr%3E%20Comprimidos%20com%205%2C0mg%20%26%23x2013%3B%20Embalagens%20contendo%2010%20ou%2030%20comprimidos.%3Cbr%3E%20Comprimidos%20com%207%2C5%20mg%20%26%23x96%3B%20Embalagem%20contendo%2030%20comprimidos.%3Cbr%3E%20USO%20ADULTO%3Cbr%3E%20USO%20ORAL%3Cbr%3E%20Composi%26%23xE7%3B%26%23xE3%3Bo%3Cbr%3E%20Cada%20comprimido%20cont%26%23xE9%3Bm%3A%3Cbr%3E%20varfarina%20s%26%23xF3%3Bdica%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B2%2C5%20mg%3B%3Cbr%3E%20excipientes%20q.s.p%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..1%20comprimido%3Cbr%3E%20(lactose%2C%20amido%2C%20corante%20amarelo%20quinole%26%23xED%3Bna%2C%2C%20amido%20glicolato%20s%26%23xF3%3Bdico%2C%20estearato%20de%20magn%26%23xE9%3Bsio%20e%20%26%23xE1%3Bgua).%3Cbr%3E%20varfarina%20s%26%23xF3%3Bdica%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B.%205%20mg%3B%3Cbr%3E%20excipientes%20q.s.p%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%201%20comprimido%3Cbr%3E%20(lactose%2C%20amido%2C%20corante%20vermelho%20ponceau%204R%2C%20amido%20glicolato%20s%26%23xF3%3Bdico%2C%20estearato%3Cbr%3E%20de%20magn%26%23xE9%3Bsio%20e%20%26%23xE1%3Bgua).%3Cbr%3E%20varfarina%20s%26%23xF3%3Bdica%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..%207%2C5%20mg%3B%3Cbr%3E%20excipientes%20q.s.p%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B1%20comprimido%3Cbr%3E%20(lactose%2C%20amido%2C%20corante%20azul%20FDC%20alum%26%23xED%3Bnio%20n%26%23xBA%3B%201%2C%20amido%20glicolato%20s%26%23xF3%3Bdico%2C%20estearato%20de%20magn%26%23xE9%3Bsio%20e%20%26%23xE1%3Bgua).%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3E%20MAREVAN%20%26%23x2013%3B%20Indica%26%23xE7%3B%26%23xF5%3Bes%20%3C%2Fh2%3E%0A%3Cp%3EA%20varfarina%2C%20como%20todos%20os%20anticoagulantes%20orais%2C%20%26%23xE9%3B%20eficaz%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20prim%26%23xE1%3Bria%20e%20secund%26%23xE1%3Bria%20do%20tromboembolismo%20venoso%2C%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20embolismo%20sist%26%23xEA%3Bmico%20em%20pacientes%20com%20pr%26%23xF3%3Btese%20de%20v%26%23xE1%3Blvulas%20card%26%23xED%3Bacas%20ou%20fibrila%26%23xE7%3B%26%23xE3%3Bo%20atrial%20e%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20acidente%20vascular%20cerebral%2C%20do%20infarto%20agudo%20do%20mioc%26%23xE1%3Brdio%20e%20da%20recorr%26%23xEA%3Bncia%20do%20infarto.%20Os%20anticoagulantes%20orais%20tamb%26%23xE9%3Bm%20est%26%23xE3%3Bo%20indicados%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20embolismo%20sist%26%23xEA%3Bmico%20em%20pacientes%20com%20doen%26%23xE7%3Ba%20valvular%20card%26%23xED%3Baca.%3C%2Fp%3E%0A%3Ch2%3E%20Contra%20indica%26%23xE7%3B%26%23xF5%3Bes%20de%20MAREVAN%20%3C%2Fh2%3E%0A%3Cp%3E%26%23x95%3B%20Grave%20doen%26%23xE7%3Ba%20hep%26%23xE1%3Btica%20ou%20renal%2C%20hemorragias%2C%20hipertens%26%23xE3%3Bo%20arterial%20grave%20n%26%23xE3%3Bo%20controlada%2C%20endocardite%20bacteriana.%20%3Cbr%3E%20%26%23x95%3B%20Durante%20as%20primeiras%2024%20(vinte%20e%20quatro)%20horas%20antes%20ou%20ap%26%23xF3%3Bs%20cirurgia%20ou%20parto.%20%3Cbr%3E%20%26%23x95%3B%20Gravidez%2C%20especialmente%20durante%20o%20primeiro%20trimestre%2C%20devido%20%26%23xE0%3B%20possibilidade%20de%20m%26%23xE1%3B-forma%26%23xE7%3B%26%23xE3%3Bo%20fetal.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20gestante%20em%20est%26%23xE1%3Bgios%20mais%20avan%26%23xE7%3Bados%20da%20gravidez%20est%26%23xE1%3B%20associada%20%26%23xE0%3B%20hemorragia%20fetal%20e%20aumento%20da%20taxa%20de%20aborto.%20%3Cbr%3E%20%26%23x95%3B%20Lactantes.%20%3Cbr%3E%20%26%23x95%3B%20Aneurisma%20cerebral%20ou%20a%26%23xF3%3Brtico%2C%20hemofilia%2C%20doen%26%23xE7%3Ba%20ulcerativa%20ativa%20do%20trato%20gastrointestinal%2C%20feridas%20ulcerativas%20abertas%2C%20aborto%20amea%26%23xE7%3Bado%20ou%20incompleto%20e%20hipersensibilidade%20a%20qualquer%20componente%20do%20produto.%20%3Cbr%3E%20%26%23x95%3B%20Indisposi%26%23xE7%3B%26%23xE3%3Bo%20ou%20incapacidade%20do%20paciente%20entender%20o%20tratamento%2C%20aus%26%23xEA%3Bncia%20de%20laborat%26%23xF3%3Brio%20confi%26%23xE1%3Bvel%20para%20realizar%20os%20testes%20de%20vigil%26%23xE2%3Bncia%20ou%20grave%20risco%20de%20intera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas.%20%3Cbr%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Ch2%3EAdvert%26%23xEA%3Bncias%3C%2Fh2%3E%0A%3Cp%3EMarevan%26%23xAE%3B%20n%26%23xE3%3Bo%20deve%20ser%20administrado%20a%20pacientes%20que%20apresentem%20sangramento%20ativo.%20Em%20geral%2C%20n%26%23xE3%3Bo%20deve%20ser%20prescrito%20a%20pacientes%20com%20risco%20de%20hemorragia%2C%20embora%20possa%20ser%20usada%20com%20extrema%20precau%26%23xE7%3B%26%23xE3%3Bo.%20Os%20pacientes%20sob%20risco%20compreendem%20aqueles%20com%20patologias%20sang%26%23xFC%3B%26%23xED%3Bneas%20hemorr%26%23xE1%3Bgicas%2C%20%26%23xFA%3Blcera%20p%26%23xE9%3Bptica%2C%20feridas%20graves%20(inclusive%20feridas%20cir%26%23xFA%3Brgicas)%20e%20endocardite%20bacteriana.%20Os%20idosos%20e%20pacientes%20com%20defici%26%23xEA%3Bncia%20de%20vitamina%20K%20requerem%20cuidado%20especial%2C%20assim%20como%20aqueles%20com%20hipertiroidismo.%20Se%20houver%20intera%26%23xE7%3B%26%23xE3%3Bo%20medicamentosa%20com%20outra%20droga%20e%20risco%20de%20hemorragia%20grave%2C%20uma%20das%20drogas%20deve%20ser%20suspensa.%20Em%20caso%20de%20suspeita%20de%20altera%26%23xE7%3B%26%23xE3%3Bo%20do%20efeito%20do%20f%26%23xE1%3Brmaco%2C%20a%20atividade%20anticoagulante%20deve%20ser%20cuidadosamente%20monitorizada%2C%20a%20fim%20de%20se%20aumentar%20ou%20diminuir%20a%20sua%20dose%2C%20se%20necess%26%23xE1%3Brio.%20O%20per%26%23xED%3Bodo%20cr%26%23xED%3Btico%20%26%23xE9%3B%20quando%20pacientes%20estabilizados%20com%20um%20anticoagulante%20iniciam%20o%20tratamento%20com%20um%20f%26%23xE1%3Brmaco%20interagente%20ou%20quando%20se%20retira%20o%20f%26%23xE1%3Brmaco%20interagente%20em%20pacientes%20antes%20estabilizados%20com%20a%20intera%26%23xE7%3B%26%23xE3%3Bo%20medicamentosa.%3C%2Fp%3E%0A%3Ch2%3EIntera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%20de%20MAREVAN%3C%2Fh2%3E%0A%3Cp%3EDeve-se%20ter%20cuidado%20no%20uso%20concomitante%20de%20qualquer%20droga%20em%20pacientes%20recebendo%20tratamento%20anticoagulante%20oral.%20A%20atividade%20da%20varfarina%20pode%20ser%20potencializada%20por%20ester%26%23xF3%3Bides%20anab%26%23xF3%3Blicos%20(ex.%3A%20etilestranol%2C%20metandrostenolona%2C%20noretrandolona)%2C%20amiodarona%2C%20amitriptilina%2Fnortriptilina%2C%20azapropazona%2C%20aztreonam%2C%20benzafibrato%2C%20cefamandol%2C%20cloranfenicol%2C%20hidrato%20de%20coral%2C%20cimetidina%2C%20ciprofloxacino%2C%20clofibrato%2C%20cotrimoxazol%2C%20danazol%2C%20destropropoxifeno%2C%20destrotiroxina%2C%20dipiridamol%2C%20eritromicina%2C%20neomicina%2C%20feprazona%2C%20fluconazol%2C%20glucagon%2C%20metronidazol%2C%20miconazol%2C%20oxifenilbutazona%2C%20fenformina%2C%20fenilbutazona%2C%20feniramidol%2C%20quinidina%2C%20salicilatos%2C%20tolbutamida%2C%20sulfonamidas%20(ex.%3A%20sulfafenazol%2C%20sulfinpirazona)%2C%20tamoxifeno%2Ctriclofos%2C%2Cdiflunisal%2C%20flurbiprofeno%2C%20indometacina%2C%20%26%23xE1%3Bcido%20mefen%26%23xE2%3Bmico%2C%20piroxicam%2C%20sulindaco%20e%2C%20possivelmente%2C%20outros%20analg%26%23xE9%3Bsicos%20antiinflamat%26%23xF3%3Brios%2C%20cetoconazol%2C%20%26%23xE1%3Bcido%20nalid%26%23xED%3Bxico%2C%20norfloxacino%2C%20tetraciclinas%20e%20outros%20antibi%26%23xF3%3Bticos%20de%20largo%20espectro%2C%2Calopurinol%2C%20dissulfiram%2C%20metilfenidato%2C%20paracetamol%2C%20drogas%20para%20tratamento%20de%20disfun%26%23xE7%3B%26%23xF5%3Bes%20da%20tire%26%23xF3%3Bide%20e%20qualquer%20droga%20potencialmente%20hepatot%26%23xF3%3Bxica.%20A%20atividade%20anticoagulante%20pode%20tamb%26%23xE9%3Bm%20ser%20aumentada%20com%20grandes%20quantidades%20ou%20ingest%26%23xE3%3Bo%20cr%26%23xF4%3Bnica%20de%20%26%23xE1%3Blcool%2C%20particularmente%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica.%20%3Cbr%3E%20Mulheres%20em%20uso%20de%20varfarina%20devem%20consultar%20o%20m%26%23xE9%3Bdico%20antes%20do%20uso%20concomitante%20de%20creme%20vaginal%20ou%20suposit%26%23xF3%3Brio%20de%20miconazol%2C%20pois%20pode%20haver%20potencializa%26%23xE7%3B%26%23xE3%3Bo%20do%20efeito%20anticoagulante.%20Tanto%20a%20potencializa%26%23xE7%3B%26%23xE3%3Bo%20quanto%20a%20inibi%26%23xE7%3B%26%23xE3%3Bo%20do%20efeito%20anticoagulante%20t%26%23xEA%3Bm%20sido%20relatadas%20com%20fenito%26%23xED%3Bna%2C%20ACTH%20e%20corticoster%26%23xF3%3Bides.%20A%20colestiramina%20e%20o%20sulcralfato%20acarretam%20insufici%26%23xEA%3Bncia%20da%20absor%26%23xE7%3B%26%23xE3%3Bo%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20atividade%20da%20varfarina.%20%3Cbr%3E%20A%20colestiramina%20pode%20tamb%26%23xE9%3Bm%20diminuir%20a%20absor%26%23xE7%3B%26%23xE3%3Bo%20de%20vitamina%20K%20sem%2C%20no%20entanto%2C%20aumentar%20a%20atividade%20anticoagulante%20da%20varfarina.%20O%20efeito%20anticoagulante%20pode%20ser%20diminu%26%23xED%3Bdo%20pela%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20vitamina%20K%2C%20inclusive%20como%20constituinte%20de%20alguns%20alimentos%2C%20como%20saladas%20verdes.%20A%20atividade%20anticoagulante%20da%20varfarina%20pode%20ser%20inibida%20por%20drogas%20que%20induzem%20as%20enzimas%20hep%26%23xE1%3Bticas%2C%20como%3A%20aminoglutetimida%2C%20barbiturato%2C%20carbamazepina%2C%20etclorvinol%2C%20glutatimida%2C%20griseofulvina%2C%20dicloralfenazona%2C%20primidona%2C%20rifampicina%20e%20contraceptivos%20orais.%3C%2Fp%3E%0A%3Ch2%3ERea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20%2F%20efeitos%20colaterais%20de%20MAREVAN%3C%2Fh2%3E%0A%3Cp%3EAs%20rea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20est%26%23xE3%3Bo%20relacionadas%20na%20tabela%20abaixo%20de%20acordo%20com%20a%20freq%26%23xFC%3B%26%23xEA%3Bncia%20do%20CIOMS%20(Council%20for%20International%20Organizations%20of%20Medical%20Sciences).%20%3Cbr%3E%20Sistema%20Corporal%20Rea%26%23xE7%3B%26%23xE3%3Bo%20adversa%20Gastrointestinal%20%3Cbr%3E%20Comum%20N%26%23xE1%3Busea%2C%20v%26%23xF4%3Bmito%20e%20diarr%26%23xE9%3Bia%2C%20flatul%26%23xEA%3Bncia%2C%20c%26%23xF3%3Blicas%20abdominais%2C%20incha%26%23xE7%3Bo%20e%20anorexia%20Incomum%20%26%23xDA%3Blceras%20da%20boca%20%3Cbr%3E%20Hepato-biliar%20Comum%20Pancreatite%20Incomum%20Aumento%20das%20concentra%26%23xE7%3B%26%23xF5%3Bes%20s%26%23xE9%3Bricas%20de%20TGO%20e%20TGP%20e%20bilirrubina.%20Rara%20Hepatite%2C%20les%26%23xF5%3Bes%20hep%26%23xE1%3Bticas%2C%20icter%26%23xED%3Bcia%20e%20les%26%23xE3%3Bo%20colest%26%23xE1%3Btica%20%3Cbr%3E%20Nervoso%20Incomum%20Cefal%26%23xE9%3Bia%20%3Cbr%3E%20Imunol%26%23xF3%3Bgico%20Rara%20Anafilaxia%20e%20alergia%20%3Cbr%3E%20Nefrol%26%23xF3%3Bgico%20Rara%20Nefropatias%20%3Cbr%3E%20Dermatol%26%23xF3%3Bgico%20Incomum%20Dermatite%2C%20urtic%26%23xE1%3Bria%2C%20exantema%2C%20prurido%20e%20alopecia%20%3Cbr%3E%20Geral%20Incomum%20Letargia%2C%20fadiga%20Rara%20Tonturas%2C%20palidez%2C%20intoler%26%23xE2%3Bncia%20ao%20frio%2C%20Muito%20comum%20%26%23x2265%3B%2010%25%20Comum%20%26%23x2265%3B%201%25%20e%20%26lt%3B%2010%25%20Incomum%20%26%23x2265%3B%200%2C1%25%20e%20%26lt%3B%201%25%20Rara%20%26%23x2265%3B%200%2C01%25%20e%20%26lt%3B%200%2C1%25%20Muito%20rara%20%26%23x2264%3B%200%2C01%25%20astenia%2C%20perda%20de%20consci%26%23xEA%3Bncia%20e%20priapismo%20%3Cbr%3E%20Sangue%20Incomum%20Leucopenia%2C%20agranulocitose%20e%20anemia%20%3Cbr%3E%20Vascular%20Comum%20Hemot%26%23xF3%3Brax%20e%20sangramento%20nasal%20Rara%20Vasculite%2C%20parestesia%2C%20hipotens%26%23xE3%3Bo%2C%20angina%20e%20coma%20Necrose%20d%26%23xE9%3Brmica%20nos%20primeiros%20dias%20de%20tratamento%20tem%20sido%20relatada%20com%20pouca%20freq%26%23xFC%3B%26%23xEA%3Bncia%20e%2C%20na%20maioria%20dos%20casos%2C%20em%20mulheres%20idosas%20e%20obesas.%20O%20primeiro%20sinal%20%26%23xE9%3B%20uma%20placa%20eritematosa%20edemaciada.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20vitamina%20K%20neste%20est%26%23xE1%3Bgio%20pode%20prevenir%20o%20desenvolvimento%20de%20equimose%20e%20infarto.%20Administrada%20no%20primeiro%20trimestre%20da%20gravidez%2C%20a%20varfarina%20pode%20causar%20uma%20s%26%23xED%3Bndrome%20varfar%26%23xED%3Bnica%20fetal%2C%20caracterizada%20por%20condrodisplasia%20punctata%20(pontilhado%20%26%23xF3%3Bsseo)%20e%20anormalidades%20faciais%20e%20do%20SNC%2C%20que%20tamb%26%23xE9%3Bm%20podem%20se%20desenvolver%20ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20no%20segundo%20e%20terceiro%20trimestres.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20gestante%2C%20em%20est%26%23xE1%3Bgios%20mais%20avan%26%23xE7%3Bados%20da%20gravidez%2C%20est%26%23xE1%3B%20associada%20%26%23xE0%3B%20hemorragia%20fetal%20e%20aumento%20da%20taxa%20de%20aborto.%20A%20incid%26%23xEA%3Bncia%20relatada%20da%20s%26%23xED%3Bndrome%20varfar%26%23xED%3Bnica%20fetal%20tem%20oscilado%20entre%205%25%20e%2030%25.%20%3Cbr%3E%20A%20VARFARINA%20%26%23xC9%3B%20RECONHECIDAMENTE%20TERATOG%26%23xCA%3BNICA.%20%3Cbr%3E%20Interfer%26%23xEA%3Bncia%20em%20exames%20laboratoriais%20%3Cbr%3E%20Com%20exce%26%23xE7%3B%26%23xE3%3Bo%20dos%20exames%20relacionados%20aos%20fatores%20da%20coagula%26%23xE7%3B%26%23xE3%3Bo%20dependentes%20da%20vitamina%20K%2C%20que%20s%26%23xE3%3Bo%20deprimidos%20pelos%20anticoagulantes%20cumar%26%23xED%3Bnicos%2C%20n%26%23xE3%3Bo%20h%26%23xE1%3B%20refer%26%23xEA%3Bncias%20de%20interfer%26%23xEA%3Bncia%20significativa%20com%20outros%20exames%20laboratoriais.%20%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EMAREVAN%20%26%23x2013%3B%20Posologia%3C%2Fh2%3E%0A%3Cp%3EA%20posologia%20de%20Marevan%26%23xAE%3B%20deve%20ser%20individualizada%20para%20cada%20paciente%2Cde%20acordo%20com%20a%20resposta%20de%20TP%2FINR%20do%20paciente%20%26%23xE0%3B%20droga.%20Dosagem%20inicial%20%26%23x2013%3B%20recomenda-se%20que%20a%20terapia%20com%20Marevan%26%23xAE%3B%20seja%20iniciada%20com%20uma%20dose%20de%202%2C5%20a%205%2C0%20mg%20ao%20dia%2C%20com%20ajustes%20posol%26%23xF3%3Bgicos%20baseados%20nos%20resultados%20das%20determina%26%23xE7%3B%26%23xF5%3Bes%20de%20TP%2FINR.%20%3Cbr%3E%20Manuten%26%23xE7%3B%26%23xE3%3Bo%20%3Cbr%3E%20%26%23x2013%3B%20na%20maioria%20dos%20pacientes%2C%20a%20resposta%20%26%23xE9%3B%20satisfatoriamente%20mantida%20com%20uma%20dose%20de%202%2C5%20a%2010%20mg%20ao%20dia.%20A%20flexibilidade%20da%20dosagem%20pode%20ser%20obtida%20partindo-se%20os%20comprimidos%20ao%20meio.%20%3Cbr%3E%20Dura%26%23xE7%3B%26%23xE3%3Bo%20da%20terapia%20%3Cbr%3E%20%26%23x2013%3B%20a%20dura%26%23xE7%3B%26%23xE3%3Bo%20da%20terapia%20para%20cada%20paciente%20deve%20ser%20individualizada.%20De%20modo%20geral%2C%20a%20terapia%20com%20anticoagulante%20deve%20ser%20continuada%20at%26%23xE9%3B%20que%20o%20risco%20de%20trombose%20e%20embolia%20seja%20eliminado.%20Dose%20perdida%20%26%23x2013%3B%20o%20efeito%20anticoagulante%20de%20Marevan%26%23xAE%3B%20persiste%20por%20mais%20de%2024%20horas.%20Se%20o%20paciente%20esquecer%20de%20tomar%20a%20dose%20prescrita%20de%20Marevan%26%23xAE%3B%20no%20hor%26%23xE1%3Brio%20marcado%2C%20a%20dose%20deve%20ser%20tomada%20assim%20que%20poss%26%23xED%3Bvel%20no%20mesmo%20dia.%20No%20dia%20seguinte%2C%20a%20dose%20esquecida%20n%26%23xE3%3Bo%20deve%20ser%20adicionalmente%20ingerida%20e%20o%20tratamento%20deve%20ser%20seguido%20normalmente.%20%3Cbr%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Ch2%3ESuper%20dosagem%3C%2Fh2%3E%0A%3Cp%3EQuadro%20cl%26%23xED%3Bnico%20%3Cbr%3E%20%26%23x2013%3B%20Hemorragia%20de%20qualquer%20tecido%20ou%20%26%23xF3%3Brg%26%23xE3%3Bo.%20Os%20sinais%20e%20sintomas%20variam%20de%20acordo%20com%20a%20localiza%26%23xE7%3B%26%23xE3%3Bo%20e%20extens%26%23xE3%3Bo%20do%20sangramento.%20A%20possibilidade%20de%20hemorragia%20deve%20ser%20considerada%20em%20qualquer%20paciente%20sob%20terapia%20anticoagulante%20que%20sofra%20quedas%2C%20quando%20n%26%23xE3%3Bo%20houver%20um%20diagn%26%23xF3%3Bstico%20%26%23xF3%3Bbvio.%20%3Cbr%3E%20O%20sangramento%20durante%20a%20terapia%20anticoagulante%20nem%20sempre%20se%20correlaciona%20com%20a%20atividade%20de%20protrombina.%20Pode%20ocorrer%20hemorragia%20adrenal%20com%20resultante%20insufici%26%23xEA%3Bncia%20supra-renal%20durante%20terapia%20anticoagulante.%20Os%20sangramentos%20que%20ocorrem%20quando%20o%20tempo%20de%20protrombina%20est%26%23xE1%3B%20dentro%20da%20faixa%20terap%26%23xEA%3Butica%20justificam%20uma%20investiga%26%23xE7%3B%26%23xE3%3Bo%20diagn%26%23xF3%3Bstica%20mais%20acurada%2C%20que%20pode%20desmascarar%20uma%20les%26%23xE3%3Bo%20pr%26%23xE9%3Bvia%20n%26%23xE3%3Bo%20suspeitada%20(ex.%3A%20tumor%2C%20%26%23xFA%3Blcera%2C%20etc).%20%3Cbr%3E%20Tratamento%20%3Cbr%3E%20%26%23x2013%3B%20A%20protrombinopenia%20excessiva%2C%20com%20ou%20sem%20sangramento%2C%20%26%23xE9%3B%20rapidamente%20controlada%20pela%20descontinua%26%23xE7%3B%26%23xE3%3Bo%20da%20varfarina%20e%2C%20se%20necess%26%23xE1%3Brio%2C%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral%20ou%20parenteral%20de%20vitamina%20K.%20O%20aparecimento%20de%20hemat%26%23xFA%3Bria%20microsc%26%23xF3%3Bpica%2C%20sangramento%20menstrual%20excessivo%2C%20melena%2C%20pet%26%23xE9%3Bquias%20ou%20sangramento%20excessivo%20por%20cortes%20ou%20ao%20barbear%2C%20s%26%23xE3%3Bo%20manifesta%26%23xE7%3B%26%23xF5%3Bes%20precoces%20de%20hipoprotrombinemia%20al%26%23xE9%3Bm%20do%20n%26%23xED%3Bvel%20seguro%20e%20satisfat%26%23xF3%3Brio.%20Para%20corre%26%23xE7%3B%26%23xE3%3Bo%20da%20protrombinopenia%20excessiva%2C%20com%20ou%20sem%20sangramento%2C%20a%20suspens%26%23xE3%3Bo%20de%20uma%20ou%20mais%20doses%20do%20medicamento%20pode%20ser%20suficiente.%20Se%20necess%26%23xE1%3Brio%2C%20doses%20pequenas%20de%20vitamina%20K%20(2%2C5%20a%2010%20mg)%20geralmente%20corrigem%20o%20dist%26%23xFA%3Brbio.%20%3Cbr%3E%20No%20caso%20de%20persist%26%23xEA%3Bncia%20de%20um%20sangramento%20menor%20ou%20evolu%26%23xE7%3B%26%23xE3%3Bo%20para%20uma%20hemorragia%20fraca%2C%20podem%20ser%20administradas%20doses%20de%205%20a%2025%20mg%20de%20vitamina%20K%20por%20via%20parenteral.%20Caso%20ocorra%20hemorragia%20grave%20ou%20estados%20protrombinop%26%23xEA%3Bnicos%20n%26%23xE3%3Bo-responsivos%20%26%23xE0%3B%20vitamina%20K%2C%20deve-se%20considerar%20a%20transfus%26%23xE3%3Bo%20de%20plasma%20fresco%20congelado%20ou%20sangue%20total.%20Na%20insufici%26%23xEA%3Bncia%20supra-renal%20decorrente%20de%20hemorragia%20adrenal%2C%20deve%20ser%20institu%26%23xED%3Bda%20prontamente%20corticoterapia%20por%20via%20intravenosa%20logo%20depois%20da%20confirma%26%23xE7%3B%26%23xE3%3Bo%20do%20diagn%26%23xF3%3Bstico.%20O%20rein%26%23xED%3Bcio%20do%20tratamento%20com%20a%20varfarina%20reverte%20o%20efeito%20da%20vitamina%20K%2C%20podendo%20ser%20obtida%20novamente%20uma%20hipoprotrombinemia%20terap%26%23xEA%3Butica.%20Foi%20relatado%20um%20estado%20de%20hipercoagulabilidade%20ap%26%23xF3%3Bs%20r%26%23xE1%3Bpida%20revers%26%23xE3%3Bo%20de%20um%20tempo%20de%20protrombina%20prolongado%2C%20por%20isso%20deve-se%20ter%20cuidado%20na%20determina%26%23xE7%3B%26%23xE3%3Bo%20da%20necessidade%20de%20tratamento%20com%20vitamina%20K.%20%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ECaracteristicas%20farmalogicas%3C%2Fh2%3E%0A%3Cp%3ECaracter%26%23xED%3Bsticas%20farmacol%26%23xF3%3Bgicas%20%3Cbr%3E%20A%20varfarina%20s%26%23xF3%3Bdica%2C%20subst%26%23xE2%3Bncia%20ativa%20de%20Marevan%26%23xAE%3B%2C%20%26%23xE9%3B%20um%20anticoagulante%20sint%26%23xE9%3Btico%20pertencente%20%26%23xE0%3B%20classe%20dos%20antagonistas%20da%20vitamina%20K.%20A%20varfarina%20%26%23xE9%3B%20uma%20mistura%20rac%26%23xEA%3Bmica%20de%20quantidades%20aproximadamente%20iguais%20de%202%20is%26%23xF4%3Bmeros%20opticamente%20ativos%2C%20as%20formas%20R%20e%20S.%20%3Cbr%3E%20Farmacodin%26%23xE2%3Bmica%20%3Cbr%3E%20Marevan%26%23xAE%3B%20atua%20por%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20forma%26%23xE7%3B%26%23xE3%3Bo%20dos%20fatores%20de%20coagula%26%23xE7%3B%26%23xE3%3Bo%20II%2C%20VII%2C%20IX%20e%20X.%20Um%20efeito%20no%20tempo%20de%20protrombina%20%26%23xE9%3B%20produzido%20em%2024%20a%2036%20horas%20ap%26%23xF3%3Bs%20a%20dose%20inicial%20e%20atinge%20o%20m%26%23xE1%3Bximo%20em%2036%20a%2048%20horas%2C%20mantendo-se%20por%2048%20horas%20ou%20mais%2C%20ap%26%23xF3%3Bs%20a%20interrup%26%23xE7%3B%26%23xE3%3Bo%20da%20administra%26%23xE7%3B%26%23xE3%3Bo.%20Dentre%20os%20compostos%204-hidroxicumar%26%23xED%3Bnicos%2C%20a%20varfarina%20%26%23xE9%3B%20o%20anticoagulante%20oral%20mais%20amplamente%20usado%2C%20devido%20ao%20seu%20in%26%23xED%3Bcio%20de%20a%26%23xE7%3B%26%23xE3%3Bo%20previs%26%23xED%3Bvel%2C%20dura%26%23xE7%3B%26%23xE3%3Bo%20da%20a%26%23xE7%3B%26%23xE3%3Bo%20e%20excelente%20biodisponibilidade.%20Farmacocin%26%23xE9%3Btica%3Cbr%3E%20%20A%20varfarina%20%26%23xE9%3B%20r%26%23xE1%3Bpida%20e%20amplamente%20absorvida%20atrav%26%23xE9%3Bs%20do%20trato%20gastrointestinal.%20Sua%20absor%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE9%3B%20praticamente%20completa%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral.%20A%20varfarina%20circula%20ligada%20a%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas%3B%20distribui-se%20amplamente%20em%20todos%20os%20tecidos%20e%20se%20acumula%20rapidamente%20no%20f%26%23xED%3Bgado%2C%20primariamente%20nos%20microssomos.%20A%20exemplo%20dos%20demais%20anticoagulantes%20cumar%26%23xED%3Bnicos%2C%20atravessa%20a%20barreira%20placent%26%23xE1%3Bria%20e%20%26%23xE9%3B%20excretada%20no%20leite%20materno.%20%3Cbr%3E%20Aproximadamente%2097%25%20da%20subst%26%23xE2%3Bncia%20apresentam-se%20ligados%20%26%23xE0%3B%20albumina%20plasm%26%23xE1%3Btica.%20Os%20dois%20is%26%23xF4%3Bmeros%20s%26%23xE3%3Bo%20metabolicamente%20transformados%20por%20vias%20diferentes.%20A%20Rvarfarina%20%26%23xE9%3B%20primariamente%20metabolizada%20por%20redu%26%23xE7%3B%26%23xE3%3Bo%20da%20cadeia%20lateral%20acetonil%20em%20varfarina%20%26%23xE1%3Blcoois%2C%20que%20s%26%23xE3%3Bo%20excretados%20na%20urina%2C%20e%20a%20S-varfarina%20%26%23xE9%3B%20metabolizada%20por%20oxida%26%23xE7%3B%26%23xE3%3Bo%20a%207-hidroxi-S-varfarina%2C%20que%20%26%23xE9%3B%20eliminada%20na%20bile.%20O%20f%26%23xE1%3Brmaco%20%26%23xE9%3B%20lentamente%20degradado%20e%20apresenta%20um%20ligeiro%20efeito%20cumulativo%2C%20capaz%20de%20manter%20a%20atividade%20de%20protrombina%20nos%20n%26%23xED%3Bveis%20desejados%2C%20apesar%20de%20eventuais%20varia%26%23xE7%3B%26%23xF5%3Bes%20nas%20dosagens%20di%26%23xE1%3Brias.%20%3Cbr%3E%20A%20varfarina%20rac%26%23xEA%3Bmica%20tem%20uma%20meia-vida%20plasm%26%23xE1%3Btica%20de%2036%20a%2042%20horas.%20A%20sua%20a%26%23xE7%3B%26%23xE3%3Bo%20se%20inicia%20dentro%20de%2024%20horas%2C%20por%20causa%20da%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20produ%26%23xE7%3B%26%23xE3%3Bo%20do%20fator%20VII%2C%20que%20tem%20uma%20meia-vida%20de%20seis%20a%20sete%20horas%2C%20mas%20o%20pico%20da%20atividade%20se%20d%26%23xE1%3B%20entre%2072%20a%2096%20horas%20devido%20%26%23xE0%3Bs%20meias-vidas%20maiores%20dos%20fatores%20II%2C%20IX%20e%20X.%20Ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral%2C%20em%20indiv%26%23xED%3Bduos%20normais%2C%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20m%26%23xE1%3Bximas%20s%26%23xE3%3Bo%20atingidas%20em%20cerca%20de%2090%20minutos.%20O%20%26%23xED%3Bndice%20normalizado%20internacional%20(INR)%20deve%20ser%20usado%20como%20par%26%23xE2%3Bmetro%20para%20o%20tratamento%20com%20anticoagulantes%20orais%20e%20preven%26%23xE7%3B%26%23xE3%3Bo%20de%20hemorragias.%20%3Cbr%3E%20A%20intensidade%20%26%23xF3%3Btima%20do%20tratamento%20anticoagulante%20varia%20com%20as%20indica%26%23xE7%3B%26%23xF5%3Bes.%20Para%20a%20maioria%20das%20indica%26%23xE7%3B%26%23xF5%3Bes%2C%20%26%23xE9%3B%20apropriado%20um%20efeito%20anticoagulante%20moderado%20com%20um%20INR%20%26%23x2013%3B%20alvo%20de%202.0%20a%203.0%20(esquema%20de%20intensidade%20moderada).%20Para%20este%20INR%20e%20uma%20tromboplastina%20com%20um%20%26%23xED%3Bndice%20internacional%20de%20sensibilidade%20(ISI)%20de%202%2C3%2C%20a%20correspondente%20rela%26%23xE7%3B%26%23xE3%3Bo%20protrombina-tempo%20%26%23xE9%3B%20de%20aproximadamente%201%2C35%20a%201%2C61.%20A%20concentra%26%23xE7%3B%26%23xE3%3Bo%20terap%26%23xEA%3Butica%20de%20varfarina%2C%20portanto%20%26%23xE9%3B%20aquela%20capaz%20de%20manter%2C%20ap%26%23xF3%3Bs%20o%20alcance%20do%20estado%20de%20equil%26%23xED%3Bbrio%2C%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20protrombina%2Ftempo%20apropriada%20para%20a%20indica%26%23xE7%3B%26%23xE3%3Bo.%20Ap%26%23xF3%3Bs%20ser%20metabolizada%20no%20f%26%23xED%3Bgado%20em%20compostos%20inativos%2C%20a%20varfarina%20%26%23xE9%3B%20eliminada%20sob%20a%20forma%20de%20varfarina%20%26%23xE1%3Blcoois%20na%20urina%20e%20de%207-hidroxi-S%20varfarina%2C%20na%20bile.%20A%20meia-vida%20de%20elimina%26%23xE7%3B%26%23xE3%3Bo%20(T1%2F2)%20da%20varfarina%20varia%20de%2025%20a%2060%20horas%20(m%26%23xE9%3Bdia%20de%2040%20horas).%20A%20sua%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%20a%26%23xE7%3B%26%23xE3%3Bo%2C%20em%20condi%26%23xE7%3B%26%23xF5%3Bes%20normais%2C%20varia%20de%20dois%20a%20cinco%20dias.%20%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EResultados%20de%20eficacia%3C%2Fh2%3E%0A%3Cp%3EEstudo1%20randomizado%2C%20duplo%20cego%2C%20com%20738%20pacientes%2C%20mostrou%20que%20a%20terapia%20com%20a%20dose%20convencional%20de%20varfarina%20%26%23xE9%3B%20mais%20efetiva%20e%20n%26%23xE3%3Bo%20est%26%23xE1%3B%20associada%20a%20maior%20risco%20de%20sangramento%20importante%2C%20quando%20comparada%20a%20terapia%20de%20baixa%20intensidade%20com%20varfarina%2C%20para%20a%20preven%26%23xE7%3B%26%23xE3%3Bo%20de%20tromboemb%26%23xF3%3Blise%20recorrente%20por%20tempo%20prolongado%20(m%26%23xE9%3Bdia%20de%20dura%26%23xE7%3B%26%23xE3%3Bo%3A%202%2C4%20anos).%20Prins%20HM%20et%20al%202%20mostraram%20que%20em%20pacientes%20com%20trombose%20venosa%20profunda%2C%20o%20uso%20de%20varfarina%20%26%23xE9%3B%20superior%20ao%20placebo%20ou%20a%20doses%20profil%26%23xE1%3Bticas%20de%20heparina%20subcut%26%23xE2%3Bnea%2C%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20de%20recorr%26%23xEA%3Bncia.%20Outros%20estudos3%20verificaram%20que%2C%20ap%26%23xF3%3Bs%20cirurgias%20ortop%26%23xE9%3Bdicas%20ou%20ginecol%26%23xF3%3Bgicas%20de%20grande%20porte%2C%20o%20uso%20de%20varfarina%20%26%23xE9%3B%20efetivo%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20da%20trombose%20venosa.%20Dados%20de%20uma%20an%26%23xE1%3Blise%20conjunta%20de%20cinco%20estudos4%20controlados%20e%20randomizados%20publicados%20em%201994%2C%20avaliaram%20a%20efic%26%23xE1%3Bcia%20e%20os%20riscos%20da%20terapia%20anti-tromb%26%23xF3%3Btica%20em%20pacientes%20com%20fibrila%26%23xE7%3B%26%23xE3%3Bo%20atrial.%20No%20grupo%20varfarina-controle%2C%201889%20pacientes%20receberam%20varfarina%20e%201802%2C%20placebo.%20%3Cbr%3E%20A%20m%26%23xE9%3Bdia%20de%20idade%20dos%20estudos%20foi%20de%2069%20anos%2C%2046%25%20dos%20pacientes%20possu%26%23xED%3Bam%20hist%26%23xF3%3Bria%20de%20hipertens%26%23xE3%3Bo%2C%206%25%20j%26%23xE1%3B%20tinham%20apresentado%20ataque%20isqu%26%23xEA%3Bmico%20transit%26%23xF3%3Brio%20ou%20AVC%20(acidente%20vascular%20cerebralderrame)%20e%2014%25%20eram%20diab%26%23xE9%3Bticos.%20A%20efic%26%23xE1%3Bcia%20da%20varfarina%20foi%20consistente%20em%20todos%20os%20estudos%20e%20subgrupos%20de%20pacientes.%20Em%20mulheres%2C%20a%20varfarina%20reduziu%20o%20risco%20de%20AVC%20em%2084%25%2C%20comparado%20a%2060%25%20nos%20homens.%20%3Cbr%3E%20A%20taxa%20anual%20de%20hemorragia%20grave%20(hemorragia%20intracraniana%2C%20necessidade%20de%20hospitaliza%26%23xE7%3B%26%23xE3%3Bo%20ou%20transfus%26%23xE3%3Bo%20de%20duas%20unidades%20de%20sangue)%20foi%20de%201%25%20para%20o%20grupo%20controle%20e%201%2C3%25%20para%20o%20grupo%20varfarina.%20Nesses%20estudos%20a%20varfarina%20reduziu%20o%20risco%20de%20AVC%20em%20pacientes%20com%20fibrila%26%23xE7%3B%26%23xE3%3Bo%20atrial%20em%2068%25%2C%20com%20praticamente%20nenhum%20aumento%20na%20freq%26%23xFC%3B%26%23xEA%3Bncia%20de%20hemorragia%20grave.%20Outro%20estudo5%20multic%26%23xEA%3Bntrico%2C%20randomizado%2C%20comparou%20a%20a%26%23xE7%3B%26%23xE3%3Bo%20da%20varfarina%20ou%20aspirina%20com%20placebo%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20AVC%20e%20do%20embolismo%20sist%26%23xEA%3Bmico%20(eventos%20prim%26%23xE1%3Brios)%2C%20tendo%20inclu%26%23xED%3Bdo%201330%20pacientes%20internados%20ou%20ambulatoriais%20com%20fibrila%26%23xE7%3B%26%23xE3%3Bo%20atrial%20de%20origem%20n%26%23xE3%3Bo%20reum%26%23xE1%3Btica%2C%20constante%20ou%20intermitente.%20No%20grupo%20varfarina%20versus%20placebo%2C%20a%20taxa%20de%20AVC%20isqu%26%23xEA%3Bmico%20e%20embolia%20sist%26%23xEA%3Bmica%20foi%20reduzida%20substancialmente%20pelo%20uso%20de%20varfarina%20(2%2C3%25%20%2Fano%20comparado%20com%207%2C4%25%20%2Fano%20no%20grupo%20placebo).%20O%20risco%20de%20evento%20prim%26%23xE1%3Brio%20ou%20morte%20foi%20reduzido%20em%2058%25%20naqueles%20do%20grupo%20varfarina.%20O%20risco%20de%20hemorragia%20significativa%20foi%20de%201%2C5%25%2C%201%2C4%25%20e%201%2C6%25%20%2F%20ano%2C%20para%20os%20pacientes%20dos%20grupos%20varfarina%2C%20aspirina%20e%20placebo%2C%20respectivamente.%20O%20Trombosis%20Prevention%20Trial6%20avaliou%20o%20uso%20de%20varfarina%20(alvo%20de%20INR%201%2C3%20a%201%2C8)%2C%20aspirina%20(75mg%2Fdia)%20ou%20ambos%2C%20para%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20primeiro%20IAM.%20Os%20resultados%20sugeriram%20que%20o%20uso%20da%20varfarina%20com%20baixa%20intensidade%20de%20anticoagula%26%23xE7%3B%26%23xE3%3Bo%20foi%20efetivo%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20de%20isquemia%20aguda%20(particularmente%20eventos%20fatais)%2C%20e%20a%20combina%26%23xE7%3B%26%23xE3%3Bo%20com%20aspirina%20foi%20mais%20efetiva%20que%20o%20uso%20isolado%2C%20com%20pequeno%20aumento%20no%20risco%20de%20hemorragias.%20O%20estudo%20WARIS%20II7%20comparou%20a%20varfarina%2C%20a%20aspirina%20ou%20ambos%20em%203630%20pacientes%20com%20IAM%2C%20randomizados%20no%20per%26%23xED%3Bodo%20de%20alta%20hospitalar%20e%20acompanhados%20por%20dois%20anos.%20Os%20desfechos%20foram%3A%20mortalidade%20total%2C%20re-infarto%20n%26%23xE3%3Bo%20fatal%20ou%20acidente%20vascular%20tromboemb%26%23xF3%3Blico.%20Esses%20eventos%20ocorreram%20em%2020%25%20dos%20pacientes%20do%20grupo%20aspirina%20(160%20mg%2Fd)%2C%2016%2C7%25%20do%20grupo%20varfarina%20(INR%20m%26%23xE9%3Bdio%202%2C8)%20e%2015%25%20dos%20pacientes%20que%20utilizaram%20ambas%20as%20drogas%20(INR%20m%26%23xE9%3Bdio%202.2%3B%20aspirina%2075%20mg%2Fd).%20A%20superioridade%20da%20associa%26%23xE7%3B%26%23xE3%3Bo%20versus%20aspirina%20foi%20altamente%20significativa%20(p%200.0005).%20N%26%23xE3%3Bo%20houve%20diferen%26%23xE7%3Ba%20significativa%20entre%20os%20dois%20grupos%20com%20varfarina.%20Sangramento%20importante%20ocorreu%20numa%20taxa%20de%200.15%25%20por%20ano%20no%20grupo%20aspirina%2C%200.58%25%20%2F%20ano%20no%20grupo%20varfarina%20e%200.52%25%20%2F%20ano%20no%20grupo%20com%20associa%26%23xE7%3B%26%23xE3%3Bo.%20%3Cbr%3E%20Em%20um%20estudo8%20prospectivo%2C%20randomizado%2C%20aberto%2C%20controlado%20com%20254%20pacientes%2C%20o%20intervalo%20livre%20de%20eventos%20tromboemb%26%23xF3%3Blicos%20foi%20significativamente%20maior%20nos%20pacientes%20com%20pr%26%23xF3%3Btese%20valvar%20card%26%23xED%3Baca%20mec%26%23xE2%3Bnica%20tratados%20apenas%20com%20varfarina%2C%20comparado%20com%20dipiridamol-aspirina%20(p%26lt%3B0.005)%20e%20pentoxifilina-aspirina%20(p%26lt%3B0.05).%20As%20taxas%20de%20eventos%20tromboemb%26%23xF3%3Blicos%20nesses%20grupos%20foram%20de%202.2%2C%208.6%20e%207.9%20%2F%20100%20pacientes%20por%20ano%2C%20respectivamente.%20%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EUsos%20em%20idosos%2C%20crian%26%23xE7%3Bas%20e%20em%20outros%20grupos%20de%20risco%3C%2Fh2%3E%0A%3Cp%3EA%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20varfarina%20em%20idosos%20deve%20ser%20realizada%20com%20muita%20cautela%20e%20monitorizac%26%23xE3%3Bo%20freq%26%23xFC%3Bente.%20A%20seguran%26%23xE7%3Ba%20e%20a%20efic%26%23xE1%3Bcia%20do%20medicamento%20varfarina%20em%20menores%20de%2018%20anos%20de%20idade%20n%26%23xE3%3Bo%20foram%20estabelecidas%20em%20estudos.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Ch2%3EArmazenagem%3C%2Fh2%3E%0A%3Cp%3EMarevan%26%23xAE%3B%20deve%20ser%20conservado%20em%20temperatura%20ambiente%20(entre%2015%26%23xBA%3B%20e%2030%26%23xBA%3BC)%2C%20em%20sua%20embalagem%20original.%20Proteger%20da%20umidade.%3C%2Fp%3E%0A%3Ch2%3EDizeres%20legais%3C%2Fh2%3E%0A%3Cp%3EVENDA%20SOB%20PRESCRI%26%23xC7%3B%26%23xC3%3BO%20M%26%23xC9%3BDICA%3Cbr%3E%20N%26%23xFA%3Bmero%20de%20lote%2C%20data%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20prazo%20de%20validade%3A%20vide%20cartucho.%3Cbr%3E%20MS%3A%201.0390.0147%3Cbr%3E%20Farm.%20Resp.%3A%20Dra.%20M%26%23xE1%3Brcia%20Weiss%20I.%20Campos%20%26%23x2013%3B%20CRF-RJ%20N%26%23xBA%3B%204499%3Cbr%3E%20Fabricado%20e%20distribu%26%23xED%3Bdo%20por%3A%3Cbr%3E%20FARMOQU%26%23xCD%3BMICA%20S%2FA.%3Cbr%3E%20Rua%20Vi%26%23xFA%3Bva%20Cl%26%23xE1%3Budio%2C%20300%20%26%23x96%3B%20Rio%20de%20Janeiro%20%26%23x2013%3B%20RJ%3Cbr%3E%20CNPJ%3A%2033.349.473%2F0003-10%3Cbr%3E%20Ind%26%23xFA%3Bstria%20Brasileira%3Cbr%3E%20SAC%200800-250110%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EMAREVAN%20%26%23x2013%3B%20Bula%20para%20o%20paciente%3C%2Fh2%3E%0A%3Cp%3EComo%20este%20medicamento%20funciona%3F%3Cbr%3E%20Marevan%26%23xAE%3B%20%26%23xE9%3B%20um%20anticoagulante%20que%20prolonga%20o%20tempo%20de%20coagula%26%23xE7%3B%26%23xE3%3Bo%20do%20sangue.%20%3Cbr%3E%20Por%20que%20este%20medicamento%20foi%20indicado%3F%20Marevan%26%23xAE%3B%20%26%23xE9%3B%20eficaz%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20tromboembolismo%20venoso%2C%20do%20embolismo%20sist%26%23xEA%3Bmico%20em%20pacientes%20com%20pr%26%23xF3%3Btese%20de%20v%26%23xE1%3Blvulas%20card%26%23xED%3Bacas%20ou%20fibrila%26%23xE7%3B%26%23xE3%3Bo%20atrial%2C%20do%20acidente%20vascular%20cerebral%2C%20do%20infarto%20agudo%20do%20mioc%26%23xE1%3Brdio%20e%20da%20recorr%26%23xEA%3Bncia%20do%20infarto.%20Os%20anticoagulantes%20orais%20tamb%26%23xE9%3Bm%20est%26%23xE3%3Bo%20indicados%20na%20preven%26%23xE7%3B%26%23xE3%3Bo%20do%20embolismo%20sist%26%23xEA%3Bmico%20em%20pacientes%20com%20doen%26%23xE7%3Ba%20valvular%20card%26%23xED%3Baca.%20%3Cbr%3E%20Quando%20n%26%23xE3%3Bo%20devo%20usar%20este%20medicamento%3F%3Cbr%3E%20A%20varfarina%20n%26%23xE3%3Bo%20deve%20ser%20administrada%20nas%20situa%26%23xE7%3B%26%23xF5%3Bes%20a%20seguir.%3Cbr%3E%20%26%23x95%3B%20Primeiras%2024%20horas%20antes%20ou%20ap%26%23xF3%3Bs%20cirurgia%20ou%20parto%3Cbr%3E%20%26%23x95%3B%20Doen%26%23xE7%3Bas%20hep%26%23xE1%3Bticas%20ou%20renais%20graves%3Cbr%3E%20%26%23x95%3B%20Hemorragias%3Cbr%3E%20%26%23x95%3B%20Hipertens%26%23xE3%3Bo%20arterial%20grave%20n%26%23xE3%3Bo%20controlada%3Cbr%3E%20%26%23x95%3B%20Endocardite%20bacteriana%3Cbr%3E%20%26%23x95%3B%20Gravidez%3Cbr%3E%20%26%23x95%3B%20Lacta%26%23xE7%3B%26%23xE3%3Bo%3Cbr%3E%20%26%23x95%3B%20Aneurisma%20cerebral%20ou%20a%26%23xF3%3Brtico%3Cbr%3E%20%26%23x95%3B%20Hemofilia%3Cbr%3E%20%26%23x95%3B%20Doen%26%23xE7%3Ba%20ulcerativa%20ativa%20do%20trato%20gastrointestinal%3Cbr%3E%20%26%23x95%3B%20Feridas%20ulcerativas%20abertas%3Cbr%3E%20%26%23x95%3B%20Amea%26%23xE7%3Ba%20de%20aborto%20ou%20aborto%20incompleto%3Cbr%3E%20%26%23x95%3B%20Indisposi%26%23xE7%3B%26%23xE3%3Bo%20ou%20incapacidade%20do%20paciente%20para%20entender%20o%20tratamento%2C%3Cbr%3E%20aus%26%23xEA%3Bncia%20de%20laborat%26%23xF3%3Brio%20confi%26%23xE1%3Bvel%20para%20realizar%20os%20testes%20de%20controle%20ou%20grave%20risco%20de%20intera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%3Cbr%3E%20%26%23x95%3B%20Crian%26%23xE7%3Bas%3Cbr%3E%20%26%23x95%3B%20Hipersensibilidade%20a%20qualquer%20componente%20do%20produto%3Cbr%3E%20Precau%26%23xE7%3B%26%23xF5%3Bes%20e%20advert%26%23xEA%3Bncias%3Cbr%3E%20%26%23x95%3B%20Marevan%26%23xAE%3B%20n%26%23xE3%3Bo%20deve%20ser%20administrado%20a%20pacientes%20que%20apresentem%20sangramento%20ativo%20e%2C%20em%20geral%2C%20n%26%23xE3%3Bo%20deve%20ser%20prescrito%20a%20pacientes%20com%20risco%20de%20hemorragia%2C%20embora%20possa%20ser%20usado%20com%20extrema%20precau%26%23xE7%3B%26%23xE3%3Bo.%20%3Cbr%3E%20%26%23x95%3B%20Os%20pacientes%20sob%20risco%20compreendem%20aqueles%20com%20doen%26%23xE7%3Bas%20sang%26%23xFC%3B%26%23xED%3Bneas%20hemorr%26%23xE1%3Bgicas%2C%20%26%23xFA%3Blcera%20p%26%23xE9%3Bptica%2C%20feridas%20graves%20(inclusive%20feridas%20cir%26%23xFA%3Brgicas)%20e%20endocardite%20bacteriana.%20%3Cbr%3E%20%26%23x95%3B%20Os%20idosos%20e%20pacientes%20com%20defici%26%23xEA%3Bncia%20de%20vitamina%20K%20requerem%20cuidado%20especial%2C%20assim%20como%20aqueles%20com%20hipertiroidismo.%20%3Cbr%3E%20%26%23x95%3B%20Se%20houver%20intera%26%23xE7%3B%26%23xE3%3Bo%20medicamentosa%20com%20outra%20droga%20e%20risco%20de%20hemorragia%20grave%2C%20uma%20das%20drogas%20deve%20ser%20suspensa.%20%3Cbr%3E%20%26%23x95%3B%20Em%20caso%20de%20suspeita%20de%20altera%26%23xE7%3B%26%23xE3%3Bo%20do%20efeito%20de%20Marevan%26%23xAE%3B%2C%20a%20atividade%20anticoagulante%20deve%20ser%20cuidadosamente%20monitorizada%2C%20a%20fim%20de%20se%20aumentar%20ou%20diminuir%20a%20sua%20dose%2C%20se%20necess%26%23xE1%3Brio.%20O%20per%26%23xED%3Bodo%20cr%26%23xED%3Btico%20%26%23xE9%3B%20quando%20pacientes%20estabilizados%20com%20um%20anticoagulante%20iniciam%20o%20tratamento%20com%20um%20medicamento%20interagente%20ou%20quando%20se%20retira%20o%20medicamento%20interagente%20em%20pacientes%20antes%20estabilizados%20com%20a%20intera%26%23xE7%3B%26%23xE3%3Bo%20medicamentosa.%20%3Cbr%3E%20%26%23x95%3B%20Se%20ocorrerem%20complica%26%23xE7%3B%26%23xF5%3Bes%20hemorr%26%23xE1%3Bgicas%20graves%2C%20deve-se%20interromper%20imediatamente%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20do%20anticoagulante.%20%3Cbr%3E%20%26%23x95%3B%20Se%20houver%20perda%20ou%20ganho%20de%20peso%2C%20o%20m%26%23xE9%3Bdico%20deve%20ser%20informado%2C%20a%20fim%20de%20verificar%20a%20necessidade%20de%20ajuste%20de%20dosagem.%20%3Cbr%3E%20%26%23x95%3B%20Informe%20o%20dentista%20ou%20m%26%23xE9%3Bdico%2C%20no%20caso%20de%20outro%20tratamento%2C%20sobre%20o%20uso%20de%20Marevan%26%23xAE%3B.%20A%20varfarina%20interage%20com%20muitos%20outros%20medicamentos.%20%3Cbr%3E%20%26%23x95%3B%20Informe%20tamb%26%23xE9%3Bm%20o%20farmac%26%23xEA%3Butico%20antes%20de%20comprar%20qualquer%20medicamento%20de%20venda%20livre%20(ex.%3A%20%26%23xE1%3Bcido%20acetilsalic%26%23xED%3Blico).%20%3Cbr%3E%20%26%23x95%3B%20Caso%20ocorra%20qualquer%20indisposi%26%23xE7%3B%26%23xE3%3Bo%20ou%20sintoma%20de%20causa%20desconhecida%2C%20o%20paciente%20dever%26%23xE1%3B%20entrar%20em%20contato%20imediatamente%20com%20o%20m%26%23xE9%3Bdico.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%20%3Cbr%3E%20Deve-se%20ter%20cuidado%20no%20uso%20concomitante%20de%20qualquer%20droga%20em%20pacientes%20recebendo%20tratamento%20anticoagulante%20oral.%20A%20atividade%20da%20varfarina%20pode%20ser%20potencializada%20por%20ester%26%23xF3%3Bides%20anab%26%23xF3%3Blicos%20como%3A%20etilestranol%2C%20metandrostenolona%2C%20(noretrandolona)%2C%20amiodarona%2C%20amitriptilina%2Fnortriptilina%2C%20azapropazona%2C%20aztreonam%2C%20benzafibrato%2C%20cefamandol%2C%20cloranfenicol%2C%20hidrato%20de%20coral%2C%20cimetidina%2C%20ciprofloxacino%2C%20clofibrato%2C%20cotrimoxazol%2C%20danazol%2C%20destropropoxifeno%2C%20destrotiroxina%2C%20dipiridamol%2C%20eritromicina%2C%20neomicina%2C%20feprazona%2C%20fluconazol%2C%20glucagon%2C%20metronidazol%2C%20miconazol%2C%20oxifenilbutazona%2C%20fenformina%2C%20fenilbutazona%2C%20feniramidol%2C%20quinidina%2C%20salicilatos%2C%20tolbutamida%2C%20sulfonamidas%20(ex%3A%20sulfafenazol%2C%20sulfinpirazona)%2C%20tamoxifeno%2C%20triclofos%2Cdiflunisal%2C%20flurbiprofeno%2C%20indometacina%2C%20%26%23xE1%3Bcido%20mefen%26%23xE2%3Bmico%2C%20piroxicam%2C%20sulindaco%20e%2C%20possivelmente%2C%20outros%20analg%26%23xE9%3Bsicos%20antiinflamat%26%23xF3%3Brios%2C%20cetoconazol%2C%20%26%23xE1%3Bcido%20nalid%26%23xED%3Bxico%2C%20norfloxacino%2C%20tetraciclinas%20e%20outros%20antibi%26%23xF3%3Bticos%20de%20largo%20espectro%2C%20alopurinol%2C%20dissulfiram%2C%20metilfenidato%2C%20paracetamol%2C%20drogas%20para%20tratamento%20de%20disfun%26%23xE7%3B%26%23xF5%3Bes%20da%20tire%26%23xF3%3Bide%20e%20qualquer%20droga%20potencialmente%20hepatot%26%23xF3%3Bxica.%20%3Cbr%3E%20A%20atividade%20anticoagulante%20pode%20tamb%26%23xE9%3Bm%20ser%20aumentada%20com%20grandes%20quantidades%20ou%20ingest%26%23xE3%3Bo%20cr%26%23xF4%3Bnica%20de%20%26%23xE1%3Blcool%2C%20particularmente%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica.%20%3Cbr%3E%20Mulheres%20em%20uso%20de%20varfarina%20devem%20consultar%20o%20m%26%23xE9%3Bdico%20antes%20do%20uso%20concomitante%20de%20creme%20vaginal%20ou%20suposit%26%23xF3%3Brio%20de%20miconazol%2C%20pois%20pode%20haver%20potencializa%26%23xE7%3B%26%23xE3%3Bo%20do%20efeito%20anticoagulante.%20Tanto%20a%20potencializa%26%23xE7%3B%26%23xE3%3Bo%20quanto%20a%20inibi%26%23xE7%3B%26%23xE3%3Bo%20do%20efeito%20anticoagulante%20t%26%23xEA%3Bm%20sido%20relatadas%20com%20fenito%26%23xED%3Bna%2C%20ACTH%20e%20corticoster%26%23xF3%3Bides.%20A%20colestiramina%20e%20o%20sulcralfato%20acarretam%20insufici%26%23xEA%3Bncia%20da%20absor%26%23xE7%3B%26%23xE3%3Bo%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20atividade%20da%20varfarina.%20A%20colestiramina%20pode%20tamb%26%23xE9%3Bm%20diminuir%20a%20absor%26%23xE7%3B%26%23xE3%3Bo%20de%20vitamina%20K%20sem%2C%20no%20entanto%2C%20aumentar%20a%20atividade%20anticoagulante%20da%20varfarina.%20%3Cbr%3E%20O%20efeito%20anticoagulante%20pode%20ser%20diminu%26%23xED%3Bdo%20pela%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20vitamina%20K%2C%20inclusive%20como%20constituinte%20de%20alguns%20alimentos%2C%20como%20saladas%20verdes.%20A%20atividade%20anticoagulante%20da%20varfarina%20pode%20ser%20inibida%20por%20drogas%20que%20induzem%20as%20enzimas%20hep%26%23xE1%3Bticas%2C%20tais%20como%3A%20aminoglutetimida%2C%20barbiturato%2C%20carbamazepina%2C%20etclorvinol%2C%20glutatimida%2C%20griseofulvina%2C%20dicloralfenazona%2C%20primidona%2C%20rifampicina%20e%20contraceptivos%20orais.%20%3Cbr%3E%20Intera%26%23xE7%3B%26%23xE3%3Bo%20com%20exames%20laboratoriais%20%3Cbr%3E%20Com%20exce%26%23xE7%3B%26%23xE3%3Bo%20dos%20exames%20relacionados%20aos%20fatores%20da%20coagula%26%23xE7%3B%26%23xE3%3Bo%20dependentes%20da%20vitamina%20K%2C%20que%20s%26%23xE3%3Bo%20deprimidos%20pelos%20anticoagulantes%20cumar%26%23xED%3Bnicos%2C%20n%26%23xE3%3Bo%20h%26%23xE1%3B%20refer%26%23xEA%3Bncia%20de%20interfer%26%23xEA%3Bncia%20significativa%20com%20outros%20exames%20laboratoriais.%20%3Cbr%3E%20Informe%20o%20m%26%23xE9%3Bdico%20do%20aparecimento%20de%20rea%26%23xE7%3B%26%23xF5%3Bes%20indesej%26%23xE1%3Bveis.%20Informe%20o%20m%26%23xE9%3Bdico%20se%20voc%26%23xEA%3B%20est%26%23xE1%3B%20fazendo%20uso%20de%20algum%20outro%20medicamento.%20N%26%23xE3%3Bo%20use%20o%20medicamento%20sem%20o%20conhecimento%20de%20seu%20m%26%23xE9%3Bdico.%20Pode%20ser%20perigoso%20para%20a%20sua%20sa%26%23xFA%3Bde.%20%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20contra-indicado%20para%20gr%26%23xE1%3Bvidas%20e%20lactantes.%20Como%20devo%20usar%20este%20medicamento%3F%20%3Cbr%3E%20Aspecto%20f%26%23xED%3Bsico%20%3Cbr%3E%20Marevan%26%23xAE%3B%202%2C5%20mg%20%26%23x96%3B%20comprimido%20amarelo%2C%20redondo%2C%20plano%2C%20chanfrado%2C%20com%20vinco%20em%20forma%20de%20cruz%20em%20um%20dos%20lados.%20Marevan%26%23xAE%3B%205%20mg%20%26%23x96%3B%20comprimido%20rosa%2C%20redondo%2C%20plano%2C%20chanfrado%2C%20com%20vinco%20em%20forma%20de%20cruz%20em%20um%20dos%20lados.%20Marevan%26%23xAE%3B%207%2C5%20mg%20%26%23x96%3B%20comprimido%20azul%2C%20redondo%2C%20plano%2C%20chanfrado%2C%20com%20vinco%20em%20forma%20de%20cruz%20em%20um%20dos%20lados.%20%3Cbr%3E%20Posologia%20%3Cbr%3E%20A%20posologia%20de%20Marevan%26%23xAE%3B%20deve%20ser%20individualizada%20para%20cada%20paciente%2C%20de%20acordo%20com%20a%20resposta%20de%20TP%2FINR%20(valores%20obtidos%20atrav%26%23xE9%3Bs%20de%20exames%20de%20sangue)%20do%20paciente%20ao%20medicamento.%20Dosagem%20inicial%20%26%23x2013%3B%20recomenda-se%20que%20a%20terapia%20com%20Marevan%26%23xAE%3B%20seja%20iniciada%20com%20uma%20dose%20de%202%2C5%20mg%20a%205%20mg%20ao%20dia%2C%20com%20ajustes%20posol%26%23xF3%3Bgicos%20baseados%20nos%20resultados%20de%20TP%2FINR.%20Manuten%26%23xE7%3B%26%23xE3%3Bo%20%26%23x2013%3B%20na%20maioria%20dos%20pacientes%2C%20a%20resposta%20%26%23xE9%3B%20satisfatoriamente%20mantida%20com%20uma%20dose%20de%202%2C5%20a%2010%20mg%20ao%20dia.%20%3Cbr%3E%20A%20flexibilidade%20da%20dosagem%20pode%20ser%20obtida%20partindo-se%20os%20comprimidos%20ao%20meio.%20Dura%26%23xE7%3B%26%23xE3%3Bo%20da%20terapia%20%26%23x2013%3B%20a%20dura%26%23xE7%3B%26%23xE3%3Bo%20da%20terapia%20para%20cada%20paciente%20deve%20ser%20individualizada.%20De%20modo%20geral%2C%20a%20terapia%20com%20anticoagulante%20deve%20ser%20continuada%20at%26%23xE9%3B%20que%20o%20risco%20de%20trombose%20e%20embolia%20seja%20eliminado.%20Dose%20perdida%20%26%23x2013%3B%20o%20efeito%20anticoagulante%20de%20Marevan%26%23xAE%3B%20persiste%20por%20mais%20de%2024%20horas.%20Se%20o%20paciente%20esquecer%20de%20tomar%20a%20dose%20prescrita%20de%20Marevan%26%23xAE%3B%20no%20hor%26%23xE1%3Brio%20marcado%2C%20a%20dose%20deve%20ser%20tomada%2C%20assim%20que%20poss%26%23xED%3Bvel%2C%20no%20mesmo%20dia.%20No%20dia%20seguinte%2C%20a%20dose%20esquecida%20n%26%23xE3%3Bo%20deve%20ser%20adicionalmente%20ingerida%20e%20o%20tratamento%20deve%20ser%20seguido%20normalmente.%20A%20dose%20nunca%20deve%20ser%20duplicada.%20Este%20medicamento%20foi%20prescrito%20pelo%20m%26%23xE9%3Bdico%20para%20voc%26%23xEA%3B%3B%20por%20isso%2C%20nunca%20o%20administre%20a%20outra%20pessoa%2C%20pois%20pode%20ser%20prejudicial%20a%20ela%2C%20ainda%20que%20os%20sintomas%20sejam%20iguais.%20A%20dose%20do%20medicamento%20depende%20dos%20resultados%20de%20exames%20de%20sangue%20que%20voc%26%23xEA%3B%20dever%26%23xE1%3B%20fazer%20periodicamente%2C%20orientado%20por%20seu%20m%26%23xE9%3Bdico.%20%3Cbr%3E%20Siga%20as%20orienta%26%23xE7%3B%26%23xF5%3Bes%20de%20seu%20m%26%23xE9%3Bdico%2C%20respeitando%20sempre%20os%20hor%26%23xE1%3Brios%2C%20as%20doses%20e%20a%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento.%20N%26%23xE3%3Bo%20interrompa%20o%20tratamento%20sem%20o%20conhecimento%20de%20seu%20m%26%23xE9%3Bdico.%20%3Cbr%3E%20Siga%20corretamente%20o%20modo%20de%20usar.%20N%26%23xE3%3Bo%20use%20o%20medicamento%20com%20prazo%20de%20validade%20vencido.%20Antes%20de%20usar%20observe%20o%20aspecto%20do%20medicamento.%20Que%20males%20este%20medicamento%20pode%20causar%3F%20%3Cbr%3E%20%26%23x95%3B%20O%20efeito%20adverso%20mais%20importante%20%26%23xE9%3B%20o%20sangramento%2C%20que%20pode%20ocorrer%20em%20qualquer%20local%2C%20desde%20o%20sangramento%20nasal%20at%26%23xE9%3B%20a%20forma%26%23xE7%3B%26%23xE3%3Bo%20de%20hematomas%20e%20anemia.%20A%20cor%20da%20urina%20pode%20se%20alterar%20pela%20presen%26%23xE7%3Ba%20de%20sangramento%20urin%26%23xE1%3Brio.%20Sangramento%20por%20pequenos%20cortes%2C%20como%20o%20que%20ocorre%20ao%20se%20barbear%2C%20pode%20demorar%20a%20estancar.%20%3Cbr%3E%20%26%23x95%3B%20Outros%20efeitos%20podem%20aparecer%2C%20como%3A%20queda%20de%20cabelo%2C%20febre%2C%20anorexia%20(disfun%26%23xE7%3B%26%23xE3%3Bo%20alimentar)%2C%20n%26%23xE1%3Buseas%2C%20v%26%23xF4%3Bmito%2C%20gases%2C%20diarr%26%23xE9%3Bia%2C%20dor%20abdominal%2C%20rea%26%23xE7%3B%26%23xF5%3Bes%20de%20hipersensibilidade%2C%20inclusive%20vermelhid%26%23xE3%3Bo%20na%20pele%2C%20urtic%26%23xE1%3Bria%2C%20cansa%26%23xE7%3Bo%2C%20dor%20de%20cabe%26%23xE7%3Ba%2C%20dor%20no%20t%26%23xF3%3Brax%2C%20intoler%26%23xE2%3Bncia%20ao%20frio%20e%20perda%20de%20consci%26%23xEA%3Bncia.%20%3Cbr%3E%20%26%23x95%3B%20Ocasionalmente%2C%20em%20pessoas%20idosas%20e%20obesas%2C%20podem%20ser%20observadas%20les%26%23xF5%3Bes%20na%20pele%2C%20inclusive%20altera%26%23xE7%3B%26%23xE3%3Bo%20da%20cor%20nos%20dedos%20dos%20p%26%23xE9%3Bs%20(colora%26%23xE7%3B%26%23xE3%3Bo%20arroxeada).%20%3Cbr%3E%20%26%23x95%3B%20O%20risco%20mais%20importante%20da%20terapia%20com%20a%20varfarina%20%26%23xE9%3B%20de%20hemorragia%20em%20v%26%23xE1%3Brios%20%26%23xF3%3Brg%26%23xE3%3Bos%2C%20com%20conseq%26%23xFC%3Bente%20forma%26%23xE7%3B%26%23xE3%3Bo%20de%20hematomas%2C%20bem%20como%20desenvolvimento%20de%20anemia.%20%3Cbr%3E%20%26%23x95%3B%20Podem%20tamb%26%23xE9%3Bm%20ser%20observados%20pancreatite%20(inflama%26%23xE7%3B%26%23xE3%3Bo%20do%20pr%26%23xE2%3Bncreas)%2C%20hemot%26%23xF3%3Brax%20(sangue%20na%20parte%20interna%20do%20peito)%20e%20sangramento%20nasal.%20Se%20forem%20observados%20quaisquer%20destes%20sintomas%20suspenda%20imediatamente%20o%20tratamento%20e%20fale%20com%20seu%20m%26%23xE9%3Bdico.%20%3Cbr%3E%20%26%23x95%3B%20Se%20administrado%20no%20primeiro%20trimestre%20da%20gravidez%2C%20Marevan%26%23xAE%3B%20pode%20causar%20pontilhado%20%26%23xF3%3Bsseo%20no%20feto%20e%20anormalidades%20faciais%20e%20do%20sistema%20nervoso%20central%2C%20que%20tamb%26%23xE9%3Bm%20podem%20se%20desenvolver%20ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20no%20segundo%20e%20terceiro%20trimestres.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20gestante%2C%20em%20est%26%23xE1%3Bgios%20mais%20avan%26%23xE7%3Bados%20da%20gravidez%2C%20est%26%23xE1%3B%20associada%20%26%23xE0%3B%20hemorragia%20fetal%20e%20aumento%20da%20taxa%20de%20aborto.%20%3Cbr%3E%20Aten%26%23xE7%3B%26%23xE3%3Bo%3A%20este%20%26%23xE9%3B%20um%20medicamento%20novo%20e%2C%20embora%20as%20pesquisas%20tenham%20indicado%20efic%26%23xE1%3Bcia%20e%20seguran%26%23xE7%3Ba%20aceit%26%23xE1%3Bveis%20para%20comercializa%26%23xE7%3B%26%23xE3%3Bo%2C%20efeitos%20indesej%26%23xE1%3Bveis%20e%20n%26%23xE3%3Bo%20conhecidos%20podem%20ocorrer.%20Neste%20caso%2C%20informe%20o%20m%26%23xE9%3Bdico.%20%3Cbr%3E%20O%20que%20fazer%20se%20algu%26%23xE9%3Bm%20usar%20uma%20grande%20quantidade%20deste%20medicamento%20de%20uma%20s%26%23xF3%3B%20vez%3F%20%3Cbr%3E%20Um%20dos%20sintomas%20que%20pode%20ocorrer%20ap%26%23xF3%3Bs%20uma%20superdosagem%20%26%23xE9%3B%20hemorragia%20de%20qualquer%20tecido%20ou%20%26%23xF3%3Brg%26%23xE3%3Bo.%20Os%20sinais%20e%20sintomas%20variam%20de%20acordo%20com%20a%20localiza%26%23xE7%3B%26%23xE3%3Bo%20e%20extens%26%23xE3%3Bo%20do%20sangramento.%20Em%20caso%20de%20dose%20excessiva%2C%20o%20paciente%20dever%26%23xE1%3B%20ser%20encaminhado%20imediatamente%20a%20um%20servi%26%23xE7%3Bo%20hospitalar.%20Onde%20e%20como%20devo%20guardar%20este%20medicamento%3F%20%3Cbr%3E%20Cuidados%20de%20conserva%26%23xE7%3B%26%23xE3%3Bo%20%3Cbr%3E%20Marevan%26%23xAE%3B%20deve%20ser%20conservado%20em%20temperatura%20ambiente%20(entre%2015%26%23xBA%3B%20e%2030%26%23xBA%3BC)%20em%20sua%20embalagem%20original.%20Proteger%20da%20umidade.%20%3Cbr%3E%20Prazo%20de%20validade%2036%20meses%20ap%26%23xF3%3Bs%20a%20data%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20impressa%20no%20cartucho.%20N%26%23xE3%3Bo%20use%20medicamentos%20com%20o%20prazo%20de%20validade%20vencido.%20%3Cbr%3E%20TODO%20MEDICAMENTO%20DEVE%20SER%20MANTIDO%20FORA%20DO%20ALCANCE%20DAS%20CRIAN%26%23xC7%3BAS.%20%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EData%20da%20bula%3C%2Fh2%3E%0A%3Cp%3E09%2F01%2F2012%3C%2Fp%3E%0A%09%09%09%09%09%09
- Ame
- Não
- ApresentarPrecoDePor
- Sim
- MedicamentoControlado
- Não
- Cashback
- Não
- Antibiotico
- Não
- Generico
- Não
Tributos e contexto fiscal
NCM, CEST e tributos são referências fiscais brasileiras e podem não se aplicar em outros países.
IBS/CBS: o cClassTrib acima vem do enquadramento do NCM; percentuais dependem da operação, regime, data e destino.